Search images on Google Product Monograph
Active Ingredients:
- octreotide (octreotide acetate), 20 MG/VIAL
DIN: 02503778
Dosage Form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE, KIT
Route(s) of Administration: INTRAMUSCULAR
Schedule: Prescription
Company: TEVA CANADA LIMITED – official site
ATC:
- H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, WHO, Wiki)
- H01C - HYPOTHALAMIC HORMONES (ATC, WHO)
- H01CB - Antigrowth hormones (ATC, WHO)
- H01CB02 - OCTREOTIDE (WHO)
Reference brand drug: Sandostatin
External Links for Octreotide For Injectable Suspension:
Search on Google
- Octreotide For Injectable Suspension side effects
- Octreotide For Injectable Suspension dosage
- octreotide side effects
- octreotide dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find octreotide for injectable suspension photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.